Hepatitis C News and Research

Latest Hepatitis C News and Research

CDC data: Adults remain unvaccinated against preventable infectious illnesses

CDC data: Adults remain unvaccinated against preventable infectious illnesses

Medivir AB reports positive interim data on Phase 2b ASPIRE study for hepatitis C

Medivir AB reports positive interim data on Phase 2b ASPIRE study for hepatitis C

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

Cyplasin selects Aurobindo Pharma to supply API component for Ribavirin drug

Cyplasin selects Aurobindo Pharma to supply API component for Ribavirin drug

Biostar third quarter net income increases 9.8% to $3.4 million

Biostar third quarter net income increases 9.8% to $3.4 million

Unilife and IMCO enter exclusive marketing program for Unitract range of 1mL safety syringes

Unilife and IMCO enter exclusive marketing program for Unitract range of 1mL safety syringes

NanoViricides' optimized FluCide drug candidates reduce viral load in H1N1 influenza virus study

NanoViricides' optimized FluCide drug candidates reduce viral load in H1N1 influenza virus study

Sinovac third quarter sales decrease 7% to $9.6 million

Sinovac third quarter sales decrease 7% to $9.6 million

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

Scientists unveil mechanism of liver regeneration

Scientists unveil mechanism of liver regeneration

GPI launches new advocacy coalition to advance embryonic stem cell research in U.S.

GPI launches new advocacy coalition to advance embryonic stem cell research in U.S.

SCYNEXIS receives four grants under QTDP program to develop cyclophilin inhibitors

SCYNEXIS receives four grants under QTDP program to develop cyclophilin inhibitors

Combination of antiviral drugs outperforms single-drug therapy in children with hepatitis C

Combination of antiviral drugs outperforms single-drug therapy in children with hepatitis C

Vertex to enroll additional treatment arm in telaprevir/VX-222 Phase 2 clinical trial for HCV

Vertex to enroll additional treatment arm in telaprevir/VX-222 Phase 2 clinical trial for HCV

Miriam Hospital receives NIH grants to improve HIV treatment for jail inmates

Miriam Hospital receives NIH grants to improve HIV treatment for jail inmates

Forceps delivery can pose risk to mother and child

Forceps delivery can pose risk to mother and child

Research report on current and evolving technologies in drug delivery

Research report on current and evolving technologies in drug delivery

Researchers examine burden of HIV and sexually transmitted diseases in China

Researchers examine burden of HIV and sexually transmitted diseases in China

Intercell aggregate revenues decrease 28.4% to EUR 21.1m in 9 months ended September 30, 2010

Intercell aggregate revenues decrease 28.4% to EUR 21.1m in 9 months ended September 30, 2010

Vaccinations do not increase risk of RA

Vaccinations do not increase risk of RA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.